190 related articles for article (PubMed ID: 9753615)
1. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.
Balimane PV; Tamai I; Guo A; Nakanishi T; Kitada H; Leibach FH; Tsuji A; Sinko PJ
Biochem Biophys Res Commun; 1998 Sep; 250(2):246-51. PubMed ID: 9753615
[TBL] [Abstract][Full Text] [Related]
2. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
3. Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.
Balimane P; Sinko P
Biopharm Drug Dispos; 2000 Jul; 21(5):165-74. PubMed ID: 11180195
[TBL] [Abstract][Full Text] [Related]
4. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
[TBL] [Abstract][Full Text] [Related]
5. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
6. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
Anand BS; Katragadda S; Mitra AK
J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of the rabbit intestinal Na+/L-proline cotransporter (IMINO system) in Xenopus laevis oocytes.
Urdaneta E; Barber A; Wright EM; Lostao MP
J Physiol Biochem; 1998 Sep; 54(3):155-60. PubMed ID: 10217212
[TBL] [Abstract][Full Text] [Related]
9. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells.
Wenzel U; Gebert I; Weintraut H; Weber WM; Clauss W; Daniel H
J Pharmacol Exp Ther; 1996 May; 277(2):831-9. PubMed ID: 8627565
[TBL] [Abstract][Full Text] [Related]
10. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
Friedrichsen GM; Chen W; Begtrup M; Lee CP; Smith PL; Borchardt RT
Eur J Pharm Sci; 2002 Jul; 16(1-2):1-13. PubMed ID: 12113886
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: An approach involving enzyme inhibitors.
Katragadda S; Talluri RS; Mitra AK
Int J Pharm; 2006 Aug; 320(1-2):104-13. PubMed ID: 16720085
[TBL] [Abstract][Full Text] [Related]
13. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats.
Sinko PJ; Balimane PV
Biopharm Drug Dispos; 1998 May; 19(4):209-17. PubMed ID: 9604120
[TBL] [Abstract][Full Text] [Related]
14. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
Sawada K; Terada T; Saito H; Hashimoto Y; Inui KI
J Pharmacol Exp Ther; 1999 Nov; 291(2):705-9. PubMed ID: 10525090
[TBL] [Abstract][Full Text] [Related]
15. Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na+/H+ exchange activity.
Kennedy DJ; Leibach FH; Ganapathy V; Thwaites DT
Pflugers Arch; 2002 Oct; 445(1):139-46. PubMed ID: 12397398
[TBL] [Abstract][Full Text] [Related]
16. Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin-Darby canine kidney clones and Caco-2 cells.
Bhardwaj RK; Herrera-Ruiz D; Sinko PJ; Gudmundsson OS; Knipp G
J Pharmacol Exp Ther; 2005 Sep; 314(3):1093-100. PubMed ID: 15901802
[TBL] [Abstract][Full Text] [Related]
17. The peptide-based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion-transporting polypeptide.
Eckhardt U; Horz JA; Petzinger E; Stüber W; Reers M; Dickneite G; Daniel H; Wagener M; Hagenbuch B; Stieger B; Meier PJ
Hepatology; 1996 Aug; 24(2):380-4. PubMed ID: 8690408
[TBL] [Abstract][Full Text] [Related]
18. Transport of amino acid-based prodrugs by the Na+- and Cl(-) -coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery.
Hatanaka T; Haramura M; Fei YJ; Miyauchi S; Bridges CC; Ganapathy PS; Smith SB; Ganapathy V; Ganapathy ME
J Pharmacol Exp Ther; 2004 Mar; 308(3):1138-47. PubMed ID: 14617696
[TBL] [Abstract][Full Text] [Related]
19. Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters.
Landowski CP; Sun D; Foster DR; Menon SS; Barnett JL; Welage LS; Ramachandran C; Amidon GL
J Pharmacol Exp Ther; 2003 Aug; 306(2):778-86. PubMed ID: 12750437
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea.
Anand BS; Mitra AK
Pharm Res; 2002 Aug; 19(8):1194-202. PubMed ID: 12240946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
